Literature DB >> 2482522

Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles.

H Perron1, C Geny, A Laurent, C Mouriquand, J Pellat, J Perret, J M Seigneurin.   

Abstract

A leptomeningeal cell line (clonal but not immortal) was isolated from lumbar-punctured cerebrospinal fluid in a patient with definite multiple sclerosis (MS). This cell line, named LM7, was characterized by immunocytochemical and ultrastructural analyses and was found to produce specific viral reverse transcriptase activity, whereas electron microscopy revealed the presence of viral particles. This patient had no antibodies against human T-leukaemia virus type 1 (HTLV-I) or human immunodeficiency viruses types 1 and 2 (HIV-1, HIV-2). Moreover, monoclonal antibodies against HTLV-I and HIV-1 failed to recognize epitopes in induced LM7 cells. The possible relationship between MS and the virus present in LM7 cells is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2482522     DOI: 10.1016/s0923-2516(89)80141-4

Source DB:  PubMed          Journal:  Res Virol        ISSN: 0923-2516


  49 in total

1.  Processed pseudogenes of human endogenous retroviruses generated by LINEs: their integration, stability, and distribution.

Authors:  Adam Pavlícek; Jan Paces; Daniel Elleder; Jirí Hejnar
Journal:  Genome Res       Date:  2002-03       Impact factor: 9.043

Review 2.  MSRV/HERV-W/syncytin and its linkage to multiple sclerosis: the usability and the hazard of a human endogenous retrovirus.

Authors:  Antonina Dolei
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

3.  Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis.

Authors:  H Perron; J A Garson; F Bedin; F Beseme; G Paranhos-Baccala; F Komurian-Pradel; F Mallet; P W Tuke; C Voisset; J L Blond; B Lalande; J M Seigneurin; B Mandrand
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

Review 4.  Does a retrovirally encoded superantigen cause multiple sclerosis?

Authors:  P Rudge
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-10       Impact factor: 10.154

5.  [Retrovirus superantigen hypothesis of multiple sclerosis].

Authors:  A Emmer; M S Staege; M E Kornhuber
Journal:  Nervenarzt       Date:  2013-10       Impact factor: 1.214

Review 6.  Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis.

Authors:  Bharath Wootla; Jens O Watzlawik; Nikolaos Stavropoulos; Nathan J Wittenberg; Harika Dasari; Murtada A Abdelrahim; John R Henley; Sang-Hyun Oh; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Opin Biol Ther       Date:  2016-03-10       Impact factor: 4.388

7.  Isolation of a C-type retrovirus from an HIV infected cell line.

Authors:  G Burtonboy; N Delferriere; B Mousset; M Heusterspreute
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

8.  Human spumaretrovirus antibody reactivity in multiple sclerosis.

Authors:  J Lycke; B Svennerholm; A Svenningsson; W Muranyi; R M Flügel; O Andersen
Journal:  J Neurol       Date:  1994-02       Impact factor: 4.849

9.  Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family.

Authors:  J L Blond; F Besème; L Duret; O Bouton; F Bedin; H Perron; B Mandrand; F Mallet
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Analysis of transcribed human endogenous retrovirus W env loci clarifies the origin of multiple sclerosis-associated retrovirus env sequences.

Authors:  Georg Laufer; Jens Mayer; Benedikt F Mueller; Nikolaus Mueller-Lantzsch; Klemens Ruprecht
Journal:  Retrovirology       Date:  2009-04-15       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.